Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage. We conducted a retrospective and descriptive observational study of patients with SLE...

Full description

Autores:

Echeverri, Andrés Felipe
Cañas Dávila, Carlos Alberto

Tipo de recurso:

Article of investigation

Fecha de publicación:

2014

Institución:

Universidad ICESI

Repositorio:

Repositorio ICESI

Idioma:

eng

OAI Identifier:

oai:repository.icesi.edu.co:10906/78485

Acceso en línea:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84893658088&partnerID=tZOtx3y1
http://hdl.handle.net/10906/78485
http://dx.doi.org/10.1155/2014/731806

Palabra clave:

Lupus eritematoso sistémico
Enfermedad Inflamatoria
Enfermedades autoinmunes

Rights

openAccess

License

https://creativecommons.org/licenses/by-nc-nd/4.0/